HomepageRPGLIFE • NSE
add
RPG Life Sciences Limited
Vorige slotkoers
₹ 2.407,95
Dag-range
₹ 2.320,00 - ₹ 2.419,90
Jaar-range
₹ 1.360,00 - ₹ 2.974,95
Beurswaarde
39,85Â mld. INR
Gem. volume
26,52K
Koers/winst
50,37
Dividendrendement
0,66%
Primaire beurs
NSE
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (INR) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 1,73Â mld. | 12,37% |
Bedrijfskosten | 729,00Â mln. | 1,57% |
Netto inkomsten | 349,30Â mln. | 32,01% |
Netto winstmarge | 20,22 | 17,42% |
Winst per aandeel | — | — |
EBITDA | 477,15Â mln. | 28,14% |
Effectief belastingtarief | 25,51% | — |
Balans
Totale activa
Totale passiva
| (INR) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 1,26Â mld. | 23,53% |
Totale activa | — | — |
Totale passiva | — | — |
Totaal aandelenvermogen | 3,79 mld. | — |
Uitstaande aandelen | 16,54 mln. | — |
Koers-boekwaardeverhouding | 10,50 | — |
Rendement op activa | — | — |
Rendement op kapitaal | 28,80% | — |
Kasstroom
Nettomutatie in liquide middelen
| (INR) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 349,30Â mln. | 32,01% |
Operationele kasstroom | — | — |
Kasstroom uit beleggingen | — | — |
Kasstroom uit financiering | — | — |
Nettomutatie in liquide middelen | — | — |
Vrije kasstroom | — | — |
Over
RPG Life Sciences is an Indian pharmaceutical company. Formerly known as Searle Ltd, RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as API; pharmaceutical formulation; and fermentation and biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia and South East Asian countries. Wikipedia
Opgericht
1993
Website
Werknemers
1.270
